Merck
MRK
#49
Rank
NZ$556.19 B
Marketcap
NZ$225.20
Share price
1.28%
Change (1 day)
71.26%
Change (1 year)

Merck (MRK) - Cash on Hand

Cash on Hand as of March 2026 : NZ$10.10 Billion

According to Merck's latest financial reports the company has NZ$10.10 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Merck - Cash on Hand chart (from 1996 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31NZ$25.14 B3.61%
2024-12-31NZ$24.27 B116.41%
2023-12-31NZ$11.21 B-46.02%
2022-12-31NZ$20.77 B75.3%
2021-12-31NZ$11.85 B6.24%
2020-12-31NZ$11.15 B-28.1%
2019-12-31NZ$15.51 B17.42%
2018-12-31NZ$13.21 B10.44%
2017-12-31NZ$11.96 B-42.2%
2016-12-31NZ$20.70 B5.53%
2015-12-31NZ$19.61 B-2.21%
2014-12-31NZ$20.06 B-5.72%
2013-12-31NZ$21.27 B8.45%
2012-12-31NZ$19.62 B2.28%
2011-12-31NZ$19.18 B21.3%
2010-12-31NZ$15.81 B19.6%
2009-12-31NZ$13.22 B39.86%
2008-12-31NZ$9.45 B-12.02%
2007-12-31NZ$10.74 B-13.12%
2006-12-31NZ$12.36 B-45.94%
2005-12-31NZ$22.87 B130.26%
2004-12-31NZ$9.93 B54.78%
2003-12-31NZ$6.41 B-32.42%
2002-12-31NZ$9.49 B20.01%
2001-12-31NZ$7.91 B-17.56%
2000-12-31NZ$9.60 B56.68%
1999-12-31NZ$6.12 B23.91%
1998-12-31NZ$4.94 B155.07%
1997-12-31NZ$1.93 B1.29%
1996-12-31NZ$1.91 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$39.08 B 286.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.36 B 22.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$23.17 B 129.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$12.93 B 27.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$9.36 B-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$21.33 B 111.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$11.37 B 12.53%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$18.58 B 83.90%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$8.08 B-20.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$6.63 B-34.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel